Stored packed red blood cell transfusion up-regulates inflammatory gene expression in circulating leukocytes

被引:64
作者
Escobar, Guillermo A.
Cheng, Aaron M.
Moore, Ernest E.
Johnson, Jeffrey L.
Tannahill, Cynthia
Baker, Henry V.
Moldawer, Lyle L.
Banerjee, Anirban
机构
[1] Univ Colorado, Hlth Sci Ctr, Denver Hlth Med Ctr, Dept Surg, Denver, CO 80204 USA
[2] Univ Florida, Coll Med, Shands Hosp, Dept Surg, Gainesville, FL USA
[3] Univ Florida, Dept Mol Genet, Gainesville, FL USA
关键词
D O I
10.1097/01.sla.0000264507.79859.f9
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Data: The transfusion of more than 6 units of packed red blood cells (PRBCs) within the first 12 hours of injury is the strongest independent predictor of multiple organ failure (MOF). This suggests that stored blood contains bioactive factors that may modify the immuno inflammatory response. Methods: To simulate postinjury major transfusions ex vivo, we obtained whole blood from 4 healthy adults and divided it into four 7-mL groups (I-IV). Group I was not diluted. Group II had 7 mL of 0.9% sterile saline (SS) added. Group III received 3.5 mL each of leuko-reduced stored PRBC and SS (simulating a major transfusion). Group IV received 3.5 mL each of SS and a hemoglobin-based oxygen carrier (PolyHeme) to evaluate the effects of hemoglobin alone. The hemoglobin content in groups III and IV was measured to be equal. Total leukocyte RNA was purified, and its gene array profiles were obtained. Results: Of the 56,475 oligonucleotide probe sets interrogated, 415 were statistically different (P < 0.001). Fourteen of the 415 probe sets were inflammatory-related. The PRBC group had a significantly different expression profile compared with the others and included up-regulation of the interleukin-8, toll-like receptor 4, cryropyrin, prostaglandin-endoperoxide synthase-2, and heparinase genes. Conclusions: PRBCs activate inflammatory genes in circulating leukocytes, which may be central to the pathogenesis of the adverse inflammatory responses that lead to postinjury MOF.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 37 条
[1]
INTERLEUKIN-8, A CHEMOTACTIC AND INFLAMMATORY CYTOKINE [J].
BAGGIOLINI, M ;
CLARKLEWIS, I .
FEBS LETTERS, 1992, 307 (01) :97-101
[2]
Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans [J].
Bame, KJ .
GLYCOBIOLOGY, 2001, 11 (06) :91R-98R
[3]
The effect of universal leukodepletion of packed red blood cells on postoperative infections in high-risk patients undergoing abdominal aortic surgery [J].
Baron, JF ;
Gourdin, M ;
Bertrand, M ;
Mercadier, A ;
Delort, J ;
Kieffer, E ;
Coriat, P .
ANESTHESIA AND ANALGESIA, 2002, 94 (03) :529-537
[4]
A prospective, randomized clinical trial of universal WBC reduction [J].
Dzik, WH ;
Anderson, JK ;
O'Neill, EM ;
Assmann, SF ;
Kalish, LA ;
Stowell, CP .
TRANSFUSION, 2002, 42 (09) :1114-1122
[5]
Heparanase: Breaking down barriers in tumors [J].
Eccles, SA .
NATURE MEDICINE, 1999, 5 (07) :735-736
[6]
The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery [J].
Gould, SA ;
Moore, EE ;
Hoyt, DB ;
Burch, JM ;
Haenel, JB ;
Garcia, J ;
DeWoskin, R ;
Moss, GS .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 187 (02) :113-120
[7]
Can post-mortem blood be used for DNA profiling after peri-mortem blood transfusion? [J].
Graham, E. A. M. ;
Tsokos, M. ;
Rutty, G. N. .
INTERNATIONAL JOURNAL OF LEGAL MEDICINE, 2007, 121 (01) :18-23
[8]
Prostaglandins as modulators of immunity [J].
Harris, SG ;
Padilla, J ;
Koumas, L ;
Ray, D ;
Phipps, RP .
TRENDS IN IMMUNOLOGY, 2002, 23 (03) :144-150
[9]
Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: A prospective study [J].
Houbiers, JG ;
vandeVelde, CJ ;
vandeWatering, LM ;
Hermans, J ;
Schreuder, S ;
Bijnen, AB ;
Pahlplatz, P ;
Schattenkerk, ME ;
Wobbes, T ;
deVries, JE ;
Klementschitsch, P ;
vandeMaas, AH ;
Brand, A .
TRANSFUSION, 1997, 37 (02) :126-134
[10]
RANDOMIZED CONTROLLED TRIAL COMPARING TRANSFUSION OF LEUKOCYTE-DEPLETED OR BUFFY-COAT-DEPLETED BLOOD IN SURGERY FOR COLORECTAL-CANCER [J].
HOUBIERS, JGA ;
BRAND, A ;
VANDEWATERING, LMG ;
HERMANS, J ;
VERWEY, PJM ;
BIJNEN, AB ;
PAHLPLATZ, P ;
SCHATTENKERK, ME ;
WOBBES, T ;
DEVRIES, JE ;
KLEMENTSCHITSCH, P ;
VANDEMAAS, AHM ;
VANDEVELDE, CJH .
LANCET, 1994, 344 (8922) :573-578